Actual Medicinal Product (AMP) - Qtern 5mg/10mg tablets (AstraZeneca UK Ltd)
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Qtern 5mg/10mg tablets | Start Date 12-12-2016 | End Date |
Summary
- Licensed Route
- Oral
- Availability Restrictions
- None
- Licensing Authority
- Medicines - MHRA/EMA
- EMA Indicator
Codes
| BNF | Start Date | End Date |
|---|---|---|
| Previous BNF 06010203 | Start Date 22-08-2017 | End Date 03-04-2022 |
| Code | Start Date | End Date |
|---|---|---|
| 33682311000001103 | 12-12-2016 |
Parent Products
-
VTMSaxagliptin + Dapagliflozin
-
VMPSaxagliptin 5mg / Dapagliflozin 10mg tablets
-
AMP(Current) Qtern 5mg/10mg tablets (AstraZ...
-
-
Actual Medicinal Product Pack (AMPP) Information
| Pack Size | Indicative Price | Discontinued |
|---|---|---|
| 28 tablet | 4956 |